Dr. Foody is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
75 Francis St
Boston, MA 02115Phone+1 857-307-1989Fax+1 857-307-1955
Education & Training
- Cleveland Clinic FoundationFellowship, Cardiovascular Disease, 1996 - 2000
- Brigham and Women's HospitalResidency, Internal Medicine, 1990 - 1993
- University of Chicago Division of the Biological Sciences The Pritzker School of MedicineClass of 1990
Certifications & Licensure
- MA State Medical License 1992 - 2026
Awards, Honors, & Recognition
- Meaningful Use Stage 1 Certification Centers for Medicare & Medicaid Services, 2012
- Whos Who in Medicine and Healthcare Marquis Whos Who
- Fellow (FACC) American College of Cardiology
Publications & Presentations
PubMed
- Characteristics and Outcomes for Hispanic/Latinx Participants With Statin Intolerance Receiving Bempedoic Acid.Fatima Rodriguez, Leslie Cho, JoAnne Foody, A Michael Lincoff, Lei Lei
Journal of the American College of Cardiology. 2024-05-28 - 49 citationsBempedoic Acid for Primary Prevention of Cardiovascular Events in Statin-Intolerant Patients.Steven E Nissen, Venu Menon, Stephen J Nicholls, Danielle Brennan, Luke Laffin
JAMA. 2023-07-11 - 9 citationsEfficacy of a centralized, blended electronic, and human intervention to improve direct oral anticoagulant adherence: Smartphones to improve rivaroxaban ADHEREnce in a...Mintu P. Turakhia, Vandana Sundaram, Shea N. Smith, Victoria Y. Ding, P. Michael Ho
American Heart Journal. 2021-03-04
Press Mentions
- European Commission Approves Yuvanci® (Single Tablet Combination Therapy [STCT] of Macitentan and Tadalafil) for Treatment of Patients with Pulmonary Arterial Hypertension (PAH)September 30th, 2024
- Landmark CLEAR Outcomes Study Demonstrates NEXLETOL (Bempedoic Acid) Tablet Is the Only LDL-C Lowering Therapy Since Statins to Reduce Hard Ischemic Events in a Broad PopulationApril 3rd, 2023
- LDL May Be an Alternative to StatinsMarch 5th, 2023
- Join now to see all
Grant Support
- Lipid Testing /Treatment In Older MI PatientsNational Institute On Aging2002–2005
Professional Memberships
- Fellow
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: